Title : Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation.

Pub. Date : 2017 May

PMID : 28567087






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Irrespective of regimen, the changes in fibrinogen and vWF:Ag levels were mainly associated with the change in ADP-mediated PR (r=0.339, p=0.008 and r=0.322, p=0.012, respectively). Adenosine Diphosphate von Willebrand factor Homo sapiens
2 CONCLUSION: In patients with NVAF, combination antiplatelet therapy showed reductions for vWF:Ag and fibrinogen levels, which may be associated with the inhibitory levels of ADP-mediated PR. Adenosine Diphosphate von Willebrand factor Homo sapiens